Get the Stockscreener App
0.2364
0.51%
-0.0012
After Hours:
.24
0.0036
+1.52%
Pomdoctor Ltd Adr stock is traded at $0.2364, with a volume of 262.11K.
It is down -0.51% in the last 24 hours and down -26.10% over the past month.
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.
See More
Previous Close:
$0.2376
Open:
$0.2395
24h Volume:
262.11K
Relative Volume:
0.11
Market Cap:
$28.18M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+6.97%
1M Performance:
-26.10%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$0.2224
$0.24
1-Week Range:
$0.205
$0.245
52-Week Range:
$0.205
$6.43
Pomdoctor Ltd Adr Stock (POM) Company Profile
Name
Pomdoctor Ltd Adr
Sector
Industry
Phone
-
Address
-
Compare POM vs HITI, PETS, RDGT, WGRX
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
POM
Pomdoctor Ltd Adr
|
0.2364 | 28.32M | 0 | 0 | 0 | 0.00 |
|
HITI
High Tide Inc
|
2.31 | 204.67M | 376.07M | -22.41M | 18.73M | -0.298 |
|
PETS
Petmed Express Inc
|
2.93 | 63.56M | 270.52M | -6.08M | 17.42M | -0.2944 |
|
RDGT
Ridgetech Inc
|
1.69 | 32.53M | 119.97M | -1.45M | 632.50K | -0.9847 |
|
WGRX
Wellgistics Health Inc
|
0.2812 | 32.09M | 28.99M | -39.20M | -3.34M | 0.00 |
Pomdoctor Ltd Adr Stock (POM) Latest News
Shareholders who lost money in American Depositary Receipts of PomDoctor, Ltd. (NASDAQ: POM) Should Contact Wolf Haldenstein Immediately - ChartMill
Shareholders who lost money in American Depositary Receipts - GlobeNewswire
Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the POMDoctor Ltd. Securities Class Action Lawsuit - ChartMill
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of POMDOCTOR LIMITED (POM) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm - GlobeNewswire Inc.
ROSEN, LEADING INVESTOR COUNSEL, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
POM Investors Have Opportunity to Lead PomDoctor Ltd. Securities Fraud Lawsuit - Barchart.com
Rosen Law Firm Urges PomDoctor Ltd. (NASDAQ: POM) Stockholders to Contact the Firm for Information About Their Rights - ChartMill
Scott+Scott Attorneys at Law LLP Files Securities Class Action Against PomDoctor, Ltd. (NASDAQ: POM) - ChartMill
Pomdoctor Deepens Medical Insurance Integration to Expand Online Chronic-Care Reach Across Major Chinese Cities - TipRanks
POM SHAREHOLDER ACTION: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 6, 2026 - Barchart.com
Pomdoctor Receives Nasdaq Deficiency Notice Over Minimum Bid Price - TipRanks
Pomdoctor expands online hospital business through pharma partnerships By Investing.com - Investing.com India
Pomdoctor Deepens Pharma Partnerships to Drive Internet Hospital Expansion in China - TipRanks
United States shares higher at close of trade; Dow Jones Industrial Average up 1.05% - Investing.com India
U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.05% - Investing.com UK
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.05% - Investing.com
Pomdoctor (POM) Losses Persist as Price-to-Sales Premium Tests Bullish Scaling Narrative - Sahm
Pomdoctor Limited Reports Strong Revenue Growth Amidst Challenging Conditions - TipRanks
Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday - Benzinga
Citi (NYSE: C) extends Token Services in Dublin with Euro transfers, 24/7 liquidity - Stock Titan
Citi (NYSE: C) lowers base lending rate to 7.00%, effective Oct 30 at Citibank, N.A. - Stock Titan
Diluted shares outstanding of PomDoctor Ltd. Unsponsored ADR – BOATS:POM - TradingView
Citi Appointed as Depositary Bank for POMDOCTOR LIMITED’s ADR Program - The AI Journal
Citigroup (NYSE:C) Stock Quote - FinancialContent
Free cash flow per share of PomDoctor Ltd. Unsponsored ADR – NASDAQ:POM - TradingView
Citigroup Reports Third Quarter 2025 Results - Business Wire
Q3 2025 Results: Citigroup Reports Results; Webcast & Conference Call at 11 a.m. ET Today - Stock Titan
Earnings calendar for: - Yahoo
$0.60 Quarterly Dividend: Citigroup to Pay Nov 26; Multiple Preferred Series Payments Announced - Stock Titan
Debt to assets ratio of PomDoctor Ltd. Unsponsored ADR – BOATS:POM - TradingView
Gross margin % of PomDoctor Ltd. Unsponsored ADR – BOATS:POM - TradingView
PomDoctor Ltd. Unsponsored ADR Balance Sheet – BOATS:POM - TradingView
Operating margin % of PomDoctor Ltd. Unsponsored ADR – BOATS:POM - TradingView
Diluted earnings per share (Diluted EPS) of PomDoctor Ltd. Unsponsored ADR – BOATS:POM - TradingView
PomDoctor Ltd. Unsponsored ADR Income Statement – BOATS:POM - TradingView
PomDoctor Ltd. Unsponsored ADR Statistics – BOATS:POM - TradingView
Diluted net income available to common stockholders of PomDoctor Ltd. Unsponsored ADR – NASDAQ:POM - TradingView
PomDoctor Ltd. Unsponsored ADR Financial Statements – BOATS:POM - TradingView
EBIT of PomDoctor Ltd. Unsponsored ADR – NASDAQ:POM - TradingView
Diluted earnings per share (Diluted EPS) of PomDoctor Ltd. Unsponsored ADR – NASDAQ:POM - TradingView
Total assets of PomDoctor Ltd. Unsponsored ADR – NASDAQ:POM - TradingView
PomDoctor Ltd. Unsponsored ADR Earnings and Revenue – BOATS:POM - TradingView
PomDoctor Ltd. Unsponsored ADR Revenue Breakdown – BOATS:POM - TradingView
Gross profit of PomDoctor Ltd. Unsponsored ADR – NASDAQ:POM - TradingView
Operating expenses (excl. COGS) of PomDoctor Ltd. Unsponsored ADR – NASDAQ:POM - TradingView
EBITDA of PomDoctor Ltd. Unsponsored ADR – NASDAQ:POM - TradingView
Should You Buy POM Stock After The PomDoctor IPO? - Barchart.com
Pomdoctor Limited (POM) Stock Price, News, Quote & History - Yahoo
Cash from financing activities of PomDoctor Ltd. Unsponsored ADR – NASDAQ:POM - TradingView
Number of employees of PomDoctor Ltd. Unsponsored ADR – NASDAQ:POM - TradingView
Operating margin % of PomDoctor Ltd. Unsponsored ADR – NASDAQ:POM - TradingView
Pomdoctor Ltd Adr Stock (POM) Financials Data
There is no financial data for Pomdoctor Ltd Adr (POM). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
10.36%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):